| Trial ID: | L5638 |
| Source ID: | NCT00975052
|
| Associated Drug: |
Sitagliptin Phosphate
|
| Title: |
A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: sitagliptin phosphate|DRUG: Comparator: metformin|DRUG: Comparator: sitagliptin and metformin|DRUG: Comparator: placebo
|
| Outcome Measures: |
Primary: Weighted average active GLP-1 (glucagonlike peptide-1) concentrations, 4 hours after the postdose meal |
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-01
|
| Completion Date: |
2006-03
|
| Results First Posted: |
|
| Last Update Posted: |
2015-08-19
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00975052
|
